Oseltamavir: Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - "3 mg" to "3mg") |
Neil.m.young (talk | contribs) (Text replacement - "5 mg" to "5mg") |
||
| Line 11: | Line 11: | ||
''5 day course'' | ''5 day course'' | ||
*1-8 months: 3mg/kg PO BID | *1-8 months: 3mg/kg PO BID | ||
*9-23 months: 3. | *9-23 months: 3.5mg/kg PO BID | ||
*2-12 years: | *2-12 years: | ||
**<15kg: 30 mg PO BID | **<15kg: 30 mg PO BID | ||
**16-23kg: | **16-23kg: 45mg PO BID | ||
**24-40kg: 60 mg PO BID | **24-40kg: 60 mg PO BID | ||
**>40kg: | **>40kg: 75mg PO BID | ||
==Special Populations== | ==Special Populations== | ||
Revision as of 09:32, 20 July 2016
General
- Type:
- Dosage Forms:
- Common Trade Names:
Adult Dosing
Influenza
75mg PO BID x5d
Pediatric Dosing
5 day course
- 1-8 months: 3mg/kg PO BID
- 9-23 months: 3.5mg/kg PO BID
- 2-12 years:
- <15kg: 30 mg PO BID
- 16-23kg: 45mg PO BID
- 24-40kg: 60 mg PO BID
- >40kg: 75mg PO BID
Special Populations
- Pregnancy Rating:
- Lactation:
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action: